Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment

M. Koncošová, N. Vrzáčková, I. Křížová, P. Tomášová, S. Rimpelová, A. Dvořák, L. Vítek, M. Rumlová, T. Ruml, J. Zelenka

. 2021 ; 22 (19) : . [pub] 20211006

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22003492

Grant support
21-11688S Czech Science Foundation

Metabolic transformation of cancer cells leads to the accumulation of lactate and significant acidification in the tumor microenvironment. Both lactate and acidosis have a well-documented impact on cancer progression and negative patient prognosis. Here, we report that cancer cells adapted to acidosis are significantly more sensitive to oxidative damage induced by hydrogen peroxide, high-dose ascorbate, and photodynamic therapy. Higher lactate concentrations abrogate the sensitization. Mechanistically, acidosis leads to a drop in antioxidant capacity caused by a compromised supply of nicotinamide adenine dinucleotide phosphate (NADPH) derived from glucose metabolism. However, lactate metabolism in the Krebs cycle restores NADPH supply and antioxidant capacity. CPI-613 (devimistat), an anticancer drug candidate, selectively eradicates the cells adapted to acidosis through inhibition of the Krebs cycle and induction of oxidative stress while completely abrogating the protective effect of lactate. Simultaneous cell treatment with tetracycline, an inhibitor of the mitochondrial proteosynthesis, further enhances the cytotoxic effect of CPI-613 under acidosis and in tumor spheroids. While there have been numerous attempts to treat cancer by neutralizing the pH of the tumor microenvironment, we alternatively suggest considering tumor acidosis as the Achilles' heel of cancer as it enables selective therapeutic induction of lethal oxidative stress.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003492
003      
CZ-PrNML
005      
20231005125253.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms221910790 $2 doi
035    __
$a (PubMed)34639130
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Koncošová, Martina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
245    10
$a Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment / $c M. Koncošová, N. Vrzáčková, I. Křížová, P. Tomášová, S. Rimpelová, A. Dvořák, L. Vítek, M. Rumlová, T. Ruml, J. Zelenka
520    9_
$a Metabolic transformation of cancer cells leads to the accumulation of lactate and significant acidification in the tumor microenvironment. Both lactate and acidosis have a well-documented impact on cancer progression and negative patient prognosis. Here, we report that cancer cells adapted to acidosis are significantly more sensitive to oxidative damage induced by hydrogen peroxide, high-dose ascorbate, and photodynamic therapy. Higher lactate concentrations abrogate the sensitization. Mechanistically, acidosis leads to a drop in antioxidant capacity caused by a compromised supply of nicotinamide adenine dinucleotide phosphate (NADPH) derived from glucose metabolism. However, lactate metabolism in the Krebs cycle restores NADPH supply and antioxidant capacity. CPI-613 (devimistat), an anticancer drug candidate, selectively eradicates the cells adapted to acidosis through inhibition of the Krebs cycle and induction of oxidative stress while completely abrogating the protective effect of lactate. Simultaneous cell treatment with tetracycline, an inhibitor of the mitochondrial proteosynthesis, further enhances the cytotoxic effect of CPI-613 under acidosis and in tumor spheroids. While there have been numerous attempts to treat cancer by neutralizing the pH of the tumor microenvironment, we alternatively suggest considering tumor acidosis as the Achilles' heel of cancer as it enables selective therapeutic induction of lethal oxidative stress.
650    _2
$a acidóza $x patofyziologie $7 D000138
650    _2
$a fyziologická adaptace $7 D000222
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a kapryláty $x farmakologie $7 D002210
650    _2
$a citrátový cyklus $x účinky léků $7 D002952
650    _2
$a energetický metabolismus $7 D004734
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a glykolýza $7 D006019
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a kyselina mléčná $x metabolismus $7 D019344
650    _2
$a mitochondrie $x účinky léků $x metabolismus $x patologie $7 D008928
650    _2
$a nádory $x farmakoterapie $x metabolismus $x patologie $7 D009369
650    _2
$a oxidační stres $7 D018384
650    _2
$a sulfidy $x farmakologie $7 D013440
650    _2
$a nádorové buňky kultivované $7 D014407
650    12
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vrzáčková, Nikola $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic $7 xx0307919
700    1_
$a Křížová, Ivana $u Department of Biotechnology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Tomášová, Petra, $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u Institute of Microbiology, The Czech Academy of Sciences, 140 00 Prague, Czech Republic $d 1989- $7 xx0268981
700    1_
$a Rimpelová, Silvie $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Dvořák, Aleš $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic
700    1_
$a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic $u 4th Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic
700    1_
$a Rumlová, Michaela $u Department of Biotechnology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Ruml, Tomáš $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Zelenka, Jaroslav $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 19 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34639130 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20231005125247 $b ABA008
999    __
$a ok $b bmc $g 1751061 $s 1154641
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 19 $e 20211006 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 21-11688S $p Czech Science Foundation
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options